Biocon Biologics eyes $200M, plans IPO in 2 years: Kiran Mazumdar-Shaw on January 26, 2020 Get link Facebook X Pinterest Email Other Apps With the funding, Biocon is looking to fund its research and development, and infuse capital to expand its biosimilars business Comments
Comments
Post a Comment